Get started
VETOQUINOLVV

VETOQUINOL

77.0EURD
−2.6−3.27%
As of today at 12:40 GMT
EUR
No trades
See on Supercharts
Overview
Financials
News Discussions Technicals Forecast Seasonals

VETO fundamentals

Key facts

Market capitalization‪941.36 M‬EUR
Dividend yield (indicated)1.07%
Price to earnings Ratio (TTM)—
Basic EPS (TTM)4.95EUR
Founded1962
Employees (FY)‪2.5 K‬
CEOMatthieu Jean Frechin
Websitevetoquinol.com
About

Vétoquinol SA operates as a global animal health company. It supplies drugs and nonmedicinal products for the livestock (cattle and pigs) and pet (dogs and cats) markets. The firm designs, develops and sells veterinary drugs and non-medicinal products in Europe, the Americas and the Asia Pacific region. It also manufactures antibiotic, anti-inflammatory, cardiology, and nephrology drugs. The company was founded by Joseph Frechin in 1933 and is headquartered in Lure, France.

Ownership
‪‪11.83 M‬‬
Closely held shares
‪‪7.97 M‬‬ (67.38%)
Free Float shares
‪‪3.86 M‬‬ (32.62%)
Closely held shares
‪‪7.97 M‬‬ (67.38%)
Free Float shares
‪‪3.86 M‬‬ (32.62%)
Capital structure
Market cap
‪‪941.36 M‬‬
Cash & equivalents
‪‪185.20 M‬‬
Enterprise value
‪‪756.16 M‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪941.36 M‬‬
Price to earning ratio (P/E)
—
Price to sales ratio (P/S)
—
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
—
Price to sales ratio (P/S)
—
Valuation ratios
‪0.00‬
‪0.60‬
‪1.20‬
‪1.80‬
‪2.40‬
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
‪0.00‬
‪6.00‬
‪12.00‬
‪18.00‬
‪24.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪8.5%‬
‪9.6%‬
‪10.7%‬
‪11.8%‬
‪12.9%‬
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
‪0.00‬
‪‪70.00 M‬‬
‪‪140.00 M‬‬
‪‪210.00 M‬‬
‪‪280.00 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪70.00 M‬‬
‪‪140.00 M‬‬
‪‪210.00 M‬‬
‪‪280.00 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪70.00 M‬‬
‪‪140.00 M‬‬
‪‪210.00 M‬‬
‪‪280.00 M‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2024
Pets
Livestock
By country
Period: 2024
Europe
United States
Americas excluding United States
Asia/Pacific (Rest of the World)

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
H1 '22
H1 '23
H2 '23
H1 '24
‪0.00‬
‪‪70.00 M‬‬
‪‪140.00 M‬‬
‪‪210.00 M‬‬
‪‪280.00 M‬‬
Actual
Estimate
Earnings
Next:Mar 19, 2026
2021
2022
2023
2024
2025
‪0.00‬
‪1.50‬
‪3.00‬
‪4.50‬
‪6.00‬
Actual
Estimate

Dividends

Dividend yield, history and sustainability

Dividend summary
0.00%
Payout ratio (TTM)
Dividend yield TTM
1.07%
Last payment
0.85
Last ex-date
Jun 4, 2024
Dividend history
‪0.55%‬
‪0.65%‬
‪0.75%‬
‪0.85%‬
‪0.95%‬
2020
2021
2022
2023
2024
‪0.00‬
‪0.22‬
‪0.44‬
‪0.66‬
‪0.88‬
Dividends per share (FY)
Dividend yield (FY) %

Financial health

Financial position and solvency of the company

Debt level and coverage
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
‪0.00‬
‪‪50.00 M‬‬
‪‪100.00 M‬‬
‪‪150.00 M‬‬
‪‪200.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
No data available
There's currently no assets and liabilities data to show.